Incidence of Ventricular Fibrillation and Sustained Ventricular Tachycardia Complicating Non-ST Segment Elevation

Asher Schnur1, Moshe Rav Acha1, Ranel Loutati1

  • 1Jesselson Heart Center, Shaare Zedek Medical Center, The Eisenberg R&D Authority, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

PubMed

Insights

Ventricular fibrillation (VF) and ventricular tachycardia (VT) are rare in non-ST elevation myocardial infarction (NSTEMI) patients. These findings suggest NSTEMI patients may not require routine intensive coronary care unit monitoring.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Critical Care

Background:

  • Ventricular arrhythmias like VF/VT are life-threatening in acute myocardial infarction (MI).
  • Data on VF/VT in non-ST elevation myocardial infarction (NSTEMI) is limited compared to STEMI.
  • Understanding VF/VT incidence in NSTEMI is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of VF/VT in NSTEMI patients admitted to an intensive coronary care unit (ICCU).
  • To evaluate the need for routine monitoring in NSTEMI patients.

Main Methods:

  • Prospective, single-center study.
  • Monitored 732 NSTEMI patients admitted to ICCU from June 2019 to December 2022.
  • Analyzed demographics, symptoms, comorbidities, and laboratory/imaging data.

Main Results:

  • Only 3 (0.4%) confirmed NSTEMI patients developed VF/VT during admission.
  • Three additional cases initially diagnosed as NSTEMI were reclassified as STEMI.
  • No deaths occurred within the 1-year follow-up period.

Conclusions:

  • VF/VT is a rare complication in NSTEMI patients managed with contemporary guidelines and early invasive strategies.
  • Routine monitoring and ICCU admission may not be necessary for all NSTEMI patients.